<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高分期刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTa ABXD6U-NVU8003KRCPQ8YLQC-＆UTM_MEDIUM = RSS＆FF = 20250320141549＆utm_source = Chrome＆fc = 20230708114047＆utm_campaign = PubMed-2＆v = 2.18.0.post9+e462414<description>心血管高分期刊：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20250320141549&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate> THU，2025年3月20日18:15:50 +0000</lastbuilddate><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>缺血性心肌病和功能性二尖瓣反流的性心脏重塑的性别差异：对预后的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：由于LV大小和FMR严重程度增加的女性表现出明显增加的不良结果风险，因此我们的发现表明，在ICM环境中，提出性别特异性CMR选择标准对FMR治疗管理的重要性。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J成像方法实践。 2025年3月19日； 3（1）：QYAF021。 doi：10.1093/ehjimp/qyaf021。 1月2025年环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：与缺血性心肌病（ICM）相关的功能性二尖瓣反流（FMR）预后的性别差异表明需要鉴定心脏重塑中的性别差异。这项研究旨在表征与FMR相关的心脏重塑的性别差异，与心脏重塑和FMR严重程度相互作用，以及使用心脏磁共振（CMR）成像的全因死亡率或心脏移植的预测指标。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：审查了2002年至2017年间参考CMR的连续患者。在中值的随访中，评估了790名患者[平均年龄：62.0（标准偏差= 11.2]年和24.7 <i>％</i>的女性）。有773名受试者具有完整的数据进行生存分析，有449个主要事件。冠状动脉疾病危险因素，药物，药物和冠状动脉的左侧和Malse and rirtrical and Malse and rirtrical and Malse and pros。在FMR增加的情况下，在lv和RV量增加的斜率上，室中的体积（ <i>p</i> &lt;或= 0.005）的体积较大（ <i>p</i> &lt;或= 0.005）（所有<i>p</i> >; 0.05） CMR程序后的干预措施，女性表现出较大的LV体积[危险比：1.04（95％置信区间：1.01-1.06）， <i>P</i> = 0.034]的原发性临床复合点的风险增加。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：由于LV大小和FMR严重程度增加的女性表现出明显增加的不良结果风险，因此我们的发现表明，在ICM环境中，提出性别特异性CMR选择标准对FMR治疗管理的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110340</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11920871/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11920871</a> | doi： <a href=https://doi.org/10.1093/ehjimp/qyaf021>10.1093/ehjimp/qyaf021</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110340</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Duygu Kocyigit Bunkaya</dc:creator><dc:creator>南希是奥布乔夫斯基</dc:creator><dc:creator>娜塔莉·胡</dc:creator><dc:creator>Zoran B Popovic</dc:creator><dc:creator>大卫·陈（David Chen）</dc:creator><dc:creator>克里斯托弗·恩格恩（Christopher Nguyen）</dc:creator><dc:creator> WH WILSON TANG</dc:creator><dc:creator> Deborah H Kwon</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊。成像方法和练习</dc:source><dc:title>缺血性心肌病和功能性二尖瓣反流的性心脏重塑的性别差异：对预后的影响</dc:title><dc:identifier>PMID：40110340</dc:identifier><dc:identifier> PMC：PMC11920871</dc:identifier><dc:identifier> doi：10.1093/ehjimp/qyaf021</dc:identifier></item><item><title>基于物联网的系统对心脏康复监测的功效：心力衰竭患者的Intelliot Pivotal试验的见解</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110225/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：基于物联网的医疗保健构成了HF患者康复的一种有希望的方法，而老年患者可能构成最有可能受益的人群。但是，需要更大的随机研究来确认我们的发现。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2024年12月19日； 6（2）：293-297。 doi：10.1093/ehjdh/ztae093。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：针对远程临床监测的数字健康解决方案在心血管护理中不断获得基础。但是，关于其对心力衰竭（HF）患者心脏康复效率的影响的证据相对有限。在Intelliot项目的背景下进行的这项研究中，我们评估了专门设计的物联网（IOT）患者监测系统对HF患者队列中心脏康复结果的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：该研究招募了19个临床稳定的HF患者，该患者包括12个月的护理标准磨合阶段和相等持续时间的远程随访阶段，从而为基于IoT的电子健康系统提供了研究对象。手机应用程序促进了设备衍生的数据传输，再加上可以访问医生的基于Web的平台。研究终点是（i）患者遵守电子健康系统使用及其与关键临床参数的关联，（ii）体育锻炼的变化程度，以及（iii）医生专用于借助E-Health System的患者提供护理的总时间。每天的基线到峰值增加计算为23.34％。系统使用与医生专用于招募患者护理的时间相关。观察到与系统使用的年龄和渐进式下水粘附率之间观察到显着的负相关性（ <i>r</i> = -0.5722， <i>p</i> = 0.02）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：基于物联网的医疗保健构成了HF患者康复的一种有希望的方法，而老年患者可能构成最有可能受益的人群。但是，需要更大的随机研究来确认我们的发现。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110225</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914715/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914715</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae093>10.1093/ehjdh/ztae093</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110225</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Maria E Marketou</dc:creator><dc:creator> ioannis anastasiou</dc:creator><dc:creator> Alexis Fourlis</dc:creator><dc:creator>阿芙罗狄蒂的阿维扎基</dc:creator><dc:creator>乔治·高克亚达克斯</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>基于物联网的系统对心脏康复监测的功效：心力衰竭患者的Intelliot Pivotal试验的见解</dc:title><dc:identifier>PMID：40110225</dc:identifier><dc:identifier> PMC：PMC11914715</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae093</dc:identifier></item><item><title>人工智能分析冠状动脉内光学相干断层扫描图像：系统评价</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>冠状动脉内光学相干断层扫描（OCT）是经皮冠状动脉血运重建和支架失败评估的围围骨围骨指导的宝贵工具。但是，手动OCT图像解释具有挑战性且耗时，这限制了广泛的临床采用。使用人工智能（AI）对OCT帧的自动分析提供了潜在的解决方案。例如，AI可用于自动化OCT图像解释，斑块... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2025年1月28日； 6（2）：270-284。 doi：10.1093/ehjdh/ZTAF005。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">冠状动脉内光学相干断层扫描（OCT）是经皮冠状动脉血运重建和支架失败评估的围围骨围骨指导的宝贵工具。但是，手动OCT图像解释具有挑战性且耗时，这限制了广泛的临床采用。使用人工智能（AI）对OCT帧的自动分析提供了潜在的解决方案。例如，AI可用于自动化OCT图像解释，斑块定量和临床事件预测。近年来已经提出了许多用于这些目的的AI模型。但是，这些模型尚未根据模型特征，性能和偏差进行系统评估。我们对用于OCT分析开发的AI模型进行了系统评价，以评估趋势和性能，包括对模型开发和评估中潜在偏见的系统评估。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110224</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914731/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914731</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztaf005>10.1093/ehjdh/ZTAF005</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110224</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Ruben GA Van der Waerden</dc:creator><dc:creator>里克·HJA Volleberg</dc:creator><dc:creator> Thijs J Luttikholt</dc:creator><dc:creator> Pierandrea Cancian</dc:creator><dc:creator> Joske L van der Zande</dc:creator><dc:creator> Gregg W Stone</dc:creator><dc:creator> Niels R Holm</dc:creator><dc:creator>埃尔文·吉迪（Elvin Kedhi）</dc:creator><dc:creator>哈维尔逃脱了</dc:creator><dc:creator>达里奥·佩莱格里尼（Dario Pellegrini）</dc:creator><dc:creator> Giulio guagliumi</dc:creator><dc:creator> Shamir R Mehta</dc:creator><dc:creator>纳塔利亚·皮尼拉（Natalia pinilla-echeverri）</dc:creator><dc:creator>劳尔·莫雷诺（RaúlMoreno）</dc:creator><dc:creator>洛伦兹·雷伯（LorenzRäber）</dc:creator><dc:creator> Tomasz Roleder</dc:creator><dc:creator> Bram van ginneken</dc:creator><dc:creator>克拉拉（Clara ISánchez）</dc:creator><dc:creator>伊万娜·伊古姆（IvanaIšgum）</dc:creator><dc:creator>尼尔斯·范罗伊（Niels van Royen）</dc:creator><dc:creator> Jos Thannhauser</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>人工智能分析冠状动脉内光学相干断层扫描图像：系统评价</dc:title><dc:identifier>PMID：40110224</dc:identifier><dc:identifier> PMC：PMC11914731</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ZTAF005</dc:identifier></item><item><title>机器学习评分以预测心脏重症监护病房住院的患者的院内结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110223/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：根据七个简单而快速的临床和超声心动图变量，在预测重症监护室的患者中，该新的ML得分是第一个在预测院内结果方面提高性能的情况。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2024年12月20日； 6（2）：218-227。 doi：10.1093/ehjdh/ztae098。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：尽管基于传统统计方法的某些分数可以用于在心脏重症监护病房（CICUS）住院的患者中的风险分层，但该领域的机器学习兴趣（ML）方法的兴趣尚未得到很好的确定。我们旨在建立一个ML模型，以预测在CICU住院的患者中的院内重大不良事件（MAE）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：2021年4月，一项法国国家前瞻性多中心研究涉及39个中心，其中包括所有连续接纳CICU的患者。主要结果是院内MAE，包括死亡，复苏心脏骤停或心源性休克。使用31个随机分配的中心作为指数队列（分为训练和测试集），评估了几种ML模型以预测院内MAE。其余八个中心用作外部验证队列。在1499例连续患者中，包括64±15岁，男性70％），有67例患有院内MAE（4.3％）。在28个临床，生物学，ECG和超声心动图变量中，有7个被选中以预测训练集（ <i>n</i> = 844）。与其他ML方法[曲线下的接收器操作特征区域（AUROC）= 0.90，Precision-Recall AUC = 0.57， <i>F</i> 1分数= 0.5]相比，增强成本敏感的C5.0技术表现出最佳性能。我们的ML得分比现有分数表现更好（AUROC：ML得分= 0.90 vs.心肌梗塞（TIMI）分数：0.56，急性冠状动脉事件全球注册表（GRACE）得分：0.52，急性心力衰竭（急性心力衰竭（急性-HF）得分：0.65；所有<i>P</i> &lt;0.05）。机器学习评分在外部队列中还表现出色（AUROC = 0.88）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：根据七个简单而快速的临床和超声心动图变量，在预测重症监护室的患者中，该新的ML得分是第一个在预测院内结果方面提高性能的情况。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">试验注册：ClinicalTrials.gov标识符：NCT05063097。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110223/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110223</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914730/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914730</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae098>10.1093/ehjdh/ztae098</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110223</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Orianne Weizman</dc:creator><dc:creator> Kenza Hamzi</dc:creator><dc:creator>帕特里克·亨利</dc:creator><dc:creator>Guillaume Schurtz</dc:creator><dc:creator>玛丽·豪格·莫罗（Marie Hauguel-Moreau）</dc:creator><dc:creator> Antonin Trimaille</dc:creator><dc:creator>马克·贝萨萨（Marc Bedossa）</dc:creator><dc:creator>让·克劳德·迪布（Jean Claude Dib）</dc:creator><dc:creator> Sabir Attou</dc:creator><dc:creator> Tanissia Boukertouta</dc:creator><dc:creator>弗兰克·博卡拉（Franck Boccara）</dc:creator><dc:creator> Thibaut Pommier</dc:creator><dc:creator> Pascal Lim</dc:creator><dc:creator>托马斯·博查顿</dc:creator><dc:creator>达米安·米什（Damien Millischer）</dc:creator><dc:creator> Benoit Merat</dc:creator><dc:creator> Fabien Picard</dc:creator><dc:creator>尼西姆·格林伯格（Nissim Grinberg）</dc:creator><dc:creator>大卫·苏尔曼（David Sulman）</dc:creator><dc:creator> Bastien Pasdeloup</dc:creator><dc:creator> Yassine El Ouahidi</dc:creator><dc:creator> TreçyGonçalves</dc:creator><dc:creator>埃里克·维卡特（Eric Vicaut）</dc:creator><dc:creator> Jean-Guillaume Dillinger</dc:creator><dc:creator> Solenn Toupin</dc:creator><dc:creator> ThéoPezel</dc:creator><dc:creator>瘾君子ICCU调查人员</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>机器学习评分以预测心脏重症监护病房住院的患者的院内结果</dc:title><dc:identifier>PMID：40110223</dc:identifier><dc:identifier> PMC：PMC11914730</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae098</dc:identifier></item><item><title>基于Sinus Rhythm心电图和临床特征，用于预测房颤患者左心房低压区域的多模式人工智能算法：回顾性，多中心研究</title><link/>https://pubmed.ncbi.nlm.nih.gov/401102222/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：多模式AI算法集成了ECG图像和临床特征，它预测了与单独使用ECG和临床LVA评分相比，LVA具有更高准确度的LVA。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2024年12月13日； 6（2）：200-208。 doi：10.1093/ehjdh/ztae095。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：我们旨在开发一种能够准确预测基于心律纤维化患者窦性心电图（ECGS）的左心房低压区域（LVA）的算法（LVA）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：该研究包括1133例接受导管消融程序的AF患者，总共分析了1787个12铅ECG图像。基于人工智能的算法用于构建用于预测LVA存在的模型。计算了LVA预测的DR-Flash和Apple临床评分。接收器操作特性（ROC）曲线和校准曲线用于评估模型性能。多中心验证包括来自五个中心的92名AF患者，共有174例心电图。从参与者获得的数据分为训练（ <i>n</i> = 906），验证（ <i>n</i> = 113）和测试集（ <i>n</i> = 114）。在所有参与者中有47.4％的人中检测到低压区域。使用单独使用ECG，卷积神经网络（CNN）模型在ROC曲线（AUROC）下达到了0.704的面积，表现优于DR-Flash得分（AUROC = 0.601）和Apple得分（AUROC = 0.589）。两种集成了ECG图像和临床特征的多模式AI模型显示出更高的诊断精度（CNN-Multimodal和CNN-Random Forest-Multimodal模型的AUROC 0.816和0.796）。我们的模型在多中心验证数据集（仅ECG，CNN-Multimodal和CNN-Random Forest-Multimotimopal模型）中也表现出色（AUROC 0.711、0.785和0.879）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：多模式AI算法集成了ECG图像和临床特征，它预测了与单独使用ECG和临床LVA评分相比，LVA具有更高准确度的LVA。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110222/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110222</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914728/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914728</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae095>10.1093/ehjdh/ztae095</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110222</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Yirao Tao</dc:creator><dc:creator> Deyun Zhang</dc:creator><dc:creator>奈登·庞</dc:creator><dc:creator>Shijia Geng</dc:creator><dc:creator>陈谭</dc:creator><dc:creator>Ying Tian</dc:creator><dc:creator> Shenda Hong</dc:creator><dc:creator> Xingpeng Liu</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>基于Sinus Rhythm心电图和临床特征，用于预测房颤患者左心房低压区域的多模式人工智能算法：回顾性，多中心研究</dc:title><dc:identifier>PMID：40110222</dc:identifier><dc:identifier> PMC：PMC11914728</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae095</dc:identifier></item><item><title>使用心电图图像预测死亡率时间的人工智能增强心电图方法的比较</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：图像2D CNN和数字化的1D CNN可从ECG图像进行死亡率预测，其性能与本质数字1D CNN相当。在本地数字1D ECG上训练的模型也可以应用于数字化的1D ECG，而性能却没有显着损失。这项工作允许AI-ECG死亡率预测应用于缺乏数字ECG基础架构的各种全球环境。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2024年11月18日； 6（2）：180-189。 doi：10.1093/ehjdh/ztae090。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：大多数人工智能增强的心电图（AI-ECG）模型用于预测包括死亡的不良事件，要求将ECG数字化存储。但是，全球大多数临床设施将ECG作为图像。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：从二级护理数据集中总共有163 401个ECG（189 539名患者），作为本质数字痕迹和PDF图像。数字化管道从PDF中提取信号。单独的1D卷积神经网络（CNN）模型在本地数字或数字化的ECG上进行了训练，具有离散的时间生存损失函数，以预测<i>死亡时间的时间</i>。在310×868 PX ECG图像上训练了2D CNN模型。来自巴西初级保健队列的958 954个ECG（645 373例）和1022名ECG（1022例患者）进行了外部验证。图像2D CNN模型和数字化的1D CNN模型在内部[C-Index 0.780（0.779-0.781），0.7772（0.771-0.774）和0.7775和0.7775和0.774-0.776（分别为0.774-0.776）和外部验证和外部验证中，在内部[C-Index 0.780（0.779-0.781）中执行了相当相当的。当对本地数字1D ECG进行培训的模型将其应用于数字化的1D ECG [C-INDEX 0.773（0.771-0.774）]。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：图像2D CNN和数字化的1D CNN可从ECG图像进行死亡率预测，其性能与本质数字1D CNN相当。在本地数字1D ECG上训练的模型也可以应用于数字化的1D ECG，而性能却没有显着损失。这项工作允许AI-ECG死亡率预测应用于缺乏数字ECG基础架构的各种全球环境。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110221</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914724/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914724</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae090>10.1093/ehjdh/ztae090</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110221</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Arunashis sau</dc:creator><dc:creator> Boroumand Zeidaabadi</dc:creator><dc:creator> Konstantinos Patlatzoglou</dc:creator><dc:creator> Libor Pastika</dc:creator><dc:creator> AntônioHRibeiro</dc:creator><dc:creator>埃斯特·萨比诺（Ester Sabino）</dc:creator><dc:creator>尼古拉斯的彼得斯</dc:creator><dc:creator>安东尼奥·路易斯·拉贝罗</dc:creator><dc:creator>丹尼尔·B·克莱默（Daniel B Kramer）</dc:creator><dc:creator>乔纳森·W·瓦克斯（Jonathan W Waks）</dc:creator><dc:creator> fu siong ng</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>使用心电图图像预测死亡率时间的人工智能增强心电图方法的比较</dc:title><dc:identifier>PMID：40110221</dc:identifier><dc:identifier> PMC：PMC11914724</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae090</dc:identifier></item><item><title>与心电图检测左心室肥大和预后的机器学习和常规标准的比较</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：基于人工智能的LVH诊断优于常规心电图标准，与超声心动图确认的LVH相比，死亡率的卓越预测指标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2025年2月11日； 6（2）：252-260。 doi：10.1093/ehjdh/ZTAF003。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：左心室肥大（LVH）在临床上很重要。当前的心电图（ECG）诊断标准不足以提早检测。这项研究旨在开发基于人工智能（AI）的算法，以提高ECG检测标准的准确性和预后价值。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：总共招募了42个016例患者（64.3±16。5年，男性为55.3％）。通过超声心动图测量计算LV质量指数。左心室肥大筛查利用了ECG标准，包括Sokolow-Lyon，Cornell产品，Cornell/菌株指数，Framingham Criterion和Peguero-lo-lo Presti。开发并验证了使用CATBOOST的AI算法（培训数据集80％和测试数据集为20％）。计算了反映精度和召回的谐波平均值的F1分数。死亡率数据是通过与国家死亡注册中心联系而获得的。基于CATBOOST的AI算法在检测LVH方面优于常规ECG标准，达到了较高的灵敏度，特异性，正预测值，F1分数和曲线下的面积。预测LVH的重要特征涉及QRS和P波形态。在中位随访期为10。1年的时间里，测试数据集中发生了1655例死亡。 Cox regression analyses showed that LVH identified by AI algorithm (hazard ratio and 95% confidence interval: 1.587, 1.309-1.924), Sokolow-Lyon (1.19, 1.038-1.365), Cornell product (1.301, 1.124-1.505), Cornell/strain index (1.306, 1.185-1.439), Framingham标准（1.174，1.062-1.298）和超声心动图确认的LVH（1.124，1.019-1.239）都与死亡率显着相关。值得注意的是，与超声心动图确认的LVH相比，AI诊断的LVH对死亡率更具预测性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：基于人工智能的LVH诊断优于常规心电图标准，与超声心动图确认的LVH相比，死亡率的卓越预测指标。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110220</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914727/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914727</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztaf003>10.1093/ehjdh/ZTAF003</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110220</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Jui-tzu黄</dc:creator><dc:creator>Chih-Hsueh Tseng</dc:creator><dc:creator> Wei-Ming Huang</dc:creator><dc:creator> Wen-Chung Yu</dc:creator><dc:creator> Hao-Min Cheng</dc:creator><dc:creator> Hsi-lu Chao</dc:creator><dc:creator> Chern-en chiang</dc:creator><dc:creator> Chen-Huan Chen</dc:creator><dc:creator>阿尔伯特·杨</dc:creator><dc:creator>Shih-Hsien演唱</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>与心电图检测左心室肥大和预后的机器学习和常规标准的比较</dc:title><dc:identifier>PMID：40110220</dc:identifier><dc:identifier> PMC：PMC11914727</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ZTAF003</dc:identifier></item><item><title>通过深度学习心电图分析的心脏骤停预测</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：深度学习模型处理ECG数据是SCA筛选的一种有前途的方法，该方法解释了由于年龄和性别而引起的SCA差异。当ECG及时到达SCA时，模型性能有所改善，尽管ECG数据距离前一年具有预测价值。与其他心电图相比，心脏骤停预测更依赖于QRS复合物数据。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2025年2月25日； 6（2）：170-179。 doi：10.1093/ehjdh/ztae088。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：突然的心脏骤停（SCA）通常是致命的事件，通常没有事先迹象。为了改善结果并启用预防策略，将心电图（ECG）与深度学习一起探讨了作为潜在的筛选工具。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：一个公开可获得的数据集，其中包含从事和没有SCA的个人的10 s铅ECG的公开数据集，有关从ECG到逮捕的时间的信息以及年龄和性别的信息进行分析，以单独预测SCA或不使用深层卷积神经网络模型。包括年龄和性别在内的基本模型，在被捕前的1天之内，ECG以及来自221个SCA患者和1046个对照的R-Waves周围720毫秒的窗户采样的数据在接收器操作特征曲线下为0.77。将灵敏度设定为95％，基本模型特异性为31％，在临床上不适用。梯度加权类激活映射显示，该模型主要依赖于QRS复合物来进行预测。但是，具有ECG的模型在逮捕前1天至1个月至1年之间记录了预测能力。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：深度学习模型处理ECG数据是SCA筛选的一种有前途的方法，该方法解释了由于年龄和性别而引起的SCA差异。当ECG及时到达SCA时，模型性能有所改善，尽管ECG数据距离前一年具有预测价值。与其他心电图相比，心脏骤停预测更依赖于QRS复合物数据。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110219</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914729/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914729</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae088>10.1093/ehjdh/ztae088</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110219</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Matt T Oberdier</dc:creator><dc:creator>卢卡·内里（Luca Neri）</dc:creator><dc:creator>亚历山德罗·奥罗（Alessandro Orro）</dc:creator><dc:creator>理查德·卡里克（Richard T Carrick）</dc:creator><dc:creator> Marco S Nobile</dc:creator><dc:creator> Sujai Jaipalli</dc:creator><dc:creator>玛丽亚姆·汗（Mariam Khan）</dc:creator><dc:creator> Stefano Diciotti</dc:creator><dc:creator>克劳迪奥·博尔吉（Claudio Borghi）</dc:creator><dc:creator>亨利·拉尔珀林</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>通过深度学习心电图分析的心脏骤停预测</dc:title><dc:identifier>PMID：40110219</dc:identifier><dc:identifier> PMC：PMC11914729</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae088</dc:identifier></item><item><title>在急性心肌梗死患者中，在可解释的增强机模型中包括HDL-2B和HDL-3的可解释的预测值</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：与HDL-2B和其他常规脂质标记相比，HDL-3为评估AMI患者的冠状动脉狭窄严重程度提供了优异的预测价值。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2024年12月23日； 6（2）：228-239。 doi：10.1093/ehjdh/ztae100。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：这项研究的目的是使用可解释的增强机（EBM）来评估与传统脂质参数在三级冠状动脉狭窄严重程度分类中，急性心肌梗塞（AMI）患者中的三级动脉狭窄严重程度分类中HDL-2B和HDL-3水平的预测值。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：在这项横断面研究中，评估了1200名AMI患者。通过微流体芯片检测对HDL亚型进行定量，并通过Gensini评分系统评估狭窄的严重程度。 Gensini分数分为三组：低组（&lt;36.5），中等组（36.5-72）和高组（>; 72）。与传统脂质标记相比，采用了可解释的增强机，一种可解释的机器学习技术来评估HDL-2B和HDL-3的预测价值。可解释的提升机用作本研究的主要模型，而逻辑回归，XGBoost和随机森林被选为预测性能的参考模型。使用接收器操作特征曲线评估模型性能。 HDL-3（％）值分为三个风险类别：低（>; 43），中度（30-43）和高（&lt;30）。将HDL-2B和HDL-3水平掺入脂质分析中会显着提高组重要性得分。四个模型的曲线值下的宏平均面积如下：逻辑模型为0.56，EBM模型为0.54，随机森林模型为0.50，XGBoost模型为0.49。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：与HDL-2B和其他常规脂质标记相比，HDL-3为评估AMI患者的冠状动脉狭窄严重程度提供了优异的预测价值。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110218</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914717/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914717</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztae100>10.1093/ehjdh/ztae100</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110218</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>本·王</dc:creator><dc:creator>李李</dc:creator><dc:creator>Yu Geng</dc:creator><dc:creator> Feifei Jin</dc:creator><dc:creator> Yujie Wang</dc:creator><dc:creator>昌瓦LV</dc:creator><dc:creator> lv</dc:creator><dc:creator> Yajun Xue</dc:creator><dc:creator>张张</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>在急性心肌梗死患者中，在可解释的增强机模型中包括HDL-2B和HDL-3的可解释的预测值</dc:title><dc:identifier>PMID：40110218</dc:identifier><dc:identifier> PMC：PMC11914717</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae100</dc:identifier></item><item><title>基于机器学习的评分系统，以预测急性冠状动脉综合征的心源性休克</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：停止冲击评分是一种简单的基于ML的工具，可在首次医疗接触时可用，显示出高性能预测ACS患者住院期间CS的高性能。 Web应用程序可在https://stopshock.org/#calculator上获得。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2025年1月6日； 6（2）：240-251。 doi：10.1093/ehjdh/ztaf002。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：心源性休克（CS）是急性冠状动脉综合征（AC）的严重并发症，死亡率接近50％。在开发CS之前鉴定高危患者的能力可能允许采取先发制人的措施以防止CS的发展。目的是使用最初医疗接触时容易获得的变量来得出并在外部验证简单的机器学习（ML）评分系统，以预测ACS患者住院期间在住院期间出现CS的风险。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：对重症监护病房住院的ACS患者的观察性多中心研究。派生队列包括来自美国波士顿贝丝以色列执事医疗中心的40万名患者。验证队列包括来自以色列Ramat Gan的Sheba医疗中心的5123名患者。最终派生队列由3228和最终验证队列组成，由4904名ACS患者组成，该患者在入院时没有CS。根据患者的报告手动裁决CS的开发。来自九个ML模型，基于13个变量（心率，呼吸率，氧气饱和度，血糖水平，收缩压，年龄，性别，性别，休克指数，心律，ACS类型，高血压史，一致性心力衰竭的病史，一致性心力衰竭和超胆固醇疾病的高胆固醇症），具有弹性网的<i>logastical</i> Net Tresciality Externalistiative Externalitival 4％（0.0）4.0（0）。 CI，0.841-0.847）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：停止冲击评分是一种简单的基于ML的工具，可在首次医疗接触时可用，显示出高性能预测ACS患者住院期间CS的高性能。 Web应用程序可在https://stopshock.org/#calculator上获得。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110217</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914733/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914733</a> | doi： <a href=https://doi.org/10.1093/ehjdh/ztaf002>10.1093/ehjdh/ztaf002</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110217</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>艾伦·伯姆</dc:creator><dc:creator>Amitai Segev</dc:creator><dc:creator> Nikola Jajcay</dc:creator><dc:creator> Konstantin a Krychtiuk</dc:creator><dc:creator> Guido Tavazzi</dc:creator><dc:creator>迈克尔·斯巴达利斯</dc:creator><dc:creator>Marta Kollarova</dc:creator><dc:creator> Imrich Berta</dc:creator><dc:creator> Jana Jankova</dc:creator><dc:creator>弗雷德里科·瓜拉（Frederico Guerra）</dc:creator><dc:creator> Edita Pogran</dc:creator><dc:creator> Andrej Remak</dc:creator><dc:creator> Milana Jarakovic</dc:creator><dc:creator> Viera Sebenova Jerigova</dc:creator><dc:creator> Katarina Petrikova</dc:creator><dc:creator> Shlomi Matetzky</dc:creator><dc:creator> Carsten Skurk</dc:creator><dc:creator>库尔特·胡伯（Kurt Huber）</dc:creator><dc:creator>布拉尼斯拉夫·贝扎克（Branislav Bezak）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊。数字健康</dc:source><dc:title>基于机器学习的评分系统，以预测急性冠状动脉综合征的心源性休克</dc:title><dc:identifier>PMID：40110217</dc:identifier><dc:identifier> PMC：PMC11914733</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztaf002</dc:identifier></item><item><title>用于护理活跃癌症患者的移动/可穿戴数字设备：ESC Council的心脏肿瘤学调查</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250320141549＆v = 2.18.0.post9+e462414<description>结论：移动/可穿戴的数字设备被认为在心脏肿瘤学不同环境中起着重要作用，包括监测患者参数和心律不齐的检测。它们在监测体育活动和QTC间隔中的作用似乎更加细微。移动/可穿戴数字设备实施的最重要的障碍被认为是其高成本。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J DIGIT健康。 2025年1月21日； 6（2）：162-169。 doi：10.1093/ehjdh/ztae082。 2025年3月的环保。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：欧洲心脏病学会心脏肿瘤学委员会开发了一项在线匿名调查，旨在总体描述当前在心脏肿瘤学中使用移动和可穿戴数字设备的实践，以及对其大规模适用性的潜在障碍。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：在2023年6月至2024年1月之间，来自55个国家的220名医疗保健专业人员完成了一份在线匿名问卷。 The greatest number of respondents reported that mobile/wearable digital devices have a role in all active cancer patients for measuring heart rate (33.9%), blood pressure (34.4%), body temperature (32.0%), physical activity (42.4%), and sleep (31.2%). In the setting of atrial fibrillation detection, respondents were evenly split between applying these technologies in all patients (33.0%) or only in selected patients (33.0%). Regarding QTc interval monitoring, 30.6% reported that mobile/wearable digital devices play a role only in selected patients. The decision to use the device was taken by the patient in 56.6% of cases and the physician in 43.4%. The most important barrier reported to mobile/wearable device implementation in the setting of cardiac rhythm monitoring and QTc measurement was their cost (weighted average: 3.38 and 3.39, respectively). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Mobile/wearable digital devices are considered to play an important role in different settings of cardio-oncology, including monitoring of patients&#39; parameters and arrhythmia detection. Their role in monitoring physical activity and QTc interval appears more nuanced. The most important perceived barrier to mobile/wearable digital device implementation is considered their high cost.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110216</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914721/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914721</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae082>10.1093/ehjdh/ztae082</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110216</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Giuseppe Boriani</dc:creator><dc:creator> Jacopo F Imberti</dc:creator><dc:creator> Riccardo Asteggiano</dc:creator><dc:creator> Pietro Ameri</dc:creator><dc:creator> Davide A Mei</dc:creator><dc:creator> Michał Farkowski</dc:creator><dc:creator> Julian Chun</dc:creator><dc:creator> Josè Luis Merino</dc:creator><dc:creator> Teresa Lopez-Fernandez</dc:creator><dc:creator> Alexander R Lyon</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology</dc:title><dc:identifier> pmid:40110216</dc:identifier><dc:identifier> pmc:PMC11914721</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae082</dc:identifier></item><item><title> Impact of a smartphone-connected remote monitoring system on self-management continuity and health awareness in cardiovascular outpatients: an exploratory survey</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110215/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSION: This pilot study suggests that a smartphone-connected remote monitoring system may enhance self-management practices and health awareness among cardiovascular outpatients. While the findings are promising, larger studies with longer follow-up periods are needed to confirm these results and evaluate the system&#39;s impact on clinical outcomes. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2024 Dec 24;6(2):289-292. doi: 10.1093/ehjdh/ztae101. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Cardiovascular diseases are a leading cause of death globally, and effective self-management is critical for patient outcomes. Integrating Internet of Things-enabled devices with smartphone applications presents a novel approach to enhancing self-management, yet challenges with digital literacy and device usability persist, especially among the elderly. This study aimed to evaluate the adherence, ease of use, and impact on health awareness of a smartphone-connected remote monitoring system among cardiovascular outpatients in Japan. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: We conducted a single-centre, prospective survey at Kumamoto University Hospital involving 10 cardiovascular outpatients (median age: 72.5 years) including heart failure ( <i>n</i> = 2), hypertension ( <i>n</i> = 3), post-cardiac surgery ( <i>n</i> = 2), and others ( <i>n</i> = 3). Participants received Bluetooth-enabled monitoring devices and a smartphone app for automatic data synchronization. Adherence, ease of use, and changes in health awareness were assessed through a structured questionnaire. The study found that 8 of 10 participants adhered to daily monitoring, with an average usage period of 48 days. Nine of 10 required minimal support with device use and 8 of 10 reported increase in health awareness. Seven of 10 indicated they could continue using it long term. The average recommendation score was 8.8/10. The timely detection of asymptomatic paroxysmal atrial fibrillation in one patient highlighted the system&#39;s potential clinical benefits. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: This pilot study suggests that a smartphone-connected remote monitoring system may enhance self-management practices and health awareness among cardiovascular outpatients. While the findings are promising, larger studies with longer follow-up periods are needed to confirm these results and evaluate the system&#39;s impact on clinical outcomes.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110215/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110215</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914722/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914722</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae101>10.1093/ehjdh/ztae101</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110215</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Masanobu Ishii</dc:creator><dc:creator> Masahiro Yamamoto</dc:creator><dc:creator> Yasuhiro Otsuka</dc:creator><dc:creator> So Ikebe</dc:creator><dc:creator> Yoshinori Yamanouchi</dc:creator><dc:creator> Kenichi Tsujita</dc:creator><dc:creator> Taishi Nakamura</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>Impact of a smartphone-connected remote monitoring system on self-management continuity and health awareness in cardiovascular outpatients: an exploratory survey</dc:title><dc:identifier> pmid:40110215</dc:identifier><dc:identifier> pmc:PMC11914722</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae101</dc:identifier></item><item><title> An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110214/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Our ensemble learning model improved doctors&#39; accuracy in detecting PH from ECG, CXR, and BNP examinations. This suggests that earlier and more accurate PH diagnosis is possible, potentially improving patient prognosis. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 16;6(2):209-217. doi: 10.1093/ehjdh/ztae097. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Delayed diagnosis of pulmonary hypertension (PH) is a known cause of poor patient prognosis. We aimed to develop an artificial intelligence (AI) model, using ensemble learning method to detect PH using electrocardiography (ECG), chest X-ray (CXR), and brain natriuretic peptide (BNP), facilitating accurate detection and prompting further examinations. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: We developed a convolutional neural network model using ECG data to predict PH, labelled by ECG from seven institutions. Logistic regression was used for the BNP prediction model. We referenced a CXR deep learning model using ResNet18. Outputs from each of the three models were integrated into a three-layer fully connected multimodal model. Ten cardiologists participated in an interpretation test, detecting PH from patients&#39; ECG, CXR, and BNP data both with and without the ensemble learning model. The area under the receiver operating characteristic curves of the ECG, CXR, BNP, and ensemble learning model were 0.818 [95% confidence interval (CI), 0.808-0.828], 0.823 (95% CI, 0.780-0.866), 0.724 (95% CI, 0.668-0.780), and 0.872 (95% CI, 0.829-0.915). Cardiologists&#39; average accuracy rates were 65.0 ± 4.7% for test without AI model and 74.0 ± 2.7% for test with AI model, a statistically significant improvement ( <i>P</i> &lt; 0.01). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Our ensemble learning model improved doctors&#39; accuracy in detecting PH from ECG, CXR, and BNP examinations. This suggests that earlier and more accurate PH diagnosis is possible, potentially improving patient prognosis.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110214/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110214</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914732/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914732</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae097>10.1093/ehjdh/ztae097</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110214</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Risa Kishikawa</dc:creator><dc:creator> Satoshi Kodera</dc:creator><dc:creator> Naoto Setoguchi</dc:creator><dc:creator> Kengo Tanabe</dc:creator><dc:creator> Shunichi Kushida</dc:creator><dc:creator> Mamoru Nanasato</dc:creator><dc:creator> Hisataka Maki</dc:creator><dc:creator> Hideo Fujita</dc:creator><dc:creator> Nahoko Kato</dc:creator><dc:creator> Hiroyuki Watanabe</dc:creator><dc:creator> Masao Takahashi</dc:creator><dc:creator> Naoko Sawada</dc:creator><dc:creator> Jiro Ando</dc:creator><dc:creator> Masataka Sato</dc:creator><dc:creator> Shinnosuke Sawano</dc:creator><dc:creator> Hiroki Shinohara</dc:creator><dc:creator> Koki Nakanishi</dc:creator><dc:creator> Shun Minatsuki</dc:creator><dc:creator> Junichi Ishida</dc:creator><dc:creator> Katsuhito Fujiu</dc:creator><dc:creator> Hiroshi Akazawa</dc:creator><dc:creator> Hiroyuki Morita</dc:creator><dc:creator> Norihiko Takeda</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide</dc:title><dc:identifier> pmid:40110214</dc:identifier><dc:identifier> pmc:PMC11914732</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae097</dc:identifier></item><item><title> Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110212/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Exercise intolerance is a primary symptom in HFpEF patients, leading to poor quality of life and HF-related adverse outcomes due to physical inactivity. The MyoMobile study was designed to investigate the use of app-based coaching to improve PA in patients with HFpEF with a personalized, home-based intervention, focusing on simple step counts for flexibility and ease of integration into daily routines. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 30;6(2):298-309. doi: 10.1093/ehjdh/ztae096. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Patients suffering from heart failure with preserved ejection fraction (HFpEF) often exhibit a sedentary lifestyle, contributing to the worsening of their condition. Although there is an inverse relationship between physical activity (PA) and adverse cardiovascular outcomes, the implementation of Class Ia PA guidelines is hindered by low participation in supervised and structured programmes, which are not suitable for a diverse population of HFpEF patients. The MyoMobile study has been designed to assess the effect of a 12-week, app-based coaching programme on promoting PA in patients with HFpEF. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: The MyoMobile study was a single-centre, randomized, controlled three-armed parallel group clinical trial with prospective data collection to investigate the effect of a personalized mobile app health intervention compared with usual care on PA levels in patients with HFpEF. Major inclusion criteria were age ≥ 45 years, a diagnosis of HFpEF, LVEF >; 40%, and current HF symptoms (NYHA Class I-III). Major exclusion criteria included acute decompensated HF, non-ambulatory status, recent acute coronary syndrome or cardiac surgery, alternative diagnoses for HF symptoms, active cancer treatment, and physical or medical conditions affecting mobility. Participants were recruited from hospitals, general practices, and practices specialized in internal medicine and cardiology in the Rhine-Main area, Germany. Participants underwent an objective 7-day PA measurement with a 3D accelerometer (Dynaport, McRoberts) at screening and after the 12-week intervention period. Following the screening, eligible participants were randomized into one of three groups: standard care (PA consulting), the intervention arm with app-based PA tracking and coaching, or the intervention arm with tracking but without coaching. The primary efficacy endpoint was the change in average daily step count between the average step count at baseline and at the end of the intervention, comparing standard care to a 12-week app-based PA coaching intervention. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Exercise intolerance is a primary symptom in HFpEF patients, leading to poor quality of life and HF-related adverse outcomes due to physical inactivity. The MyoMobile study was designed to investigate the use of app-based coaching to improve PA in patients with HFpEF with a personalized, home-based intervention, focusing on simple step counts for flexibility and ease of integration into daily routines. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov/ct2/show/NCT04940312. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> UNIQUE IDENTIFIER: NCT04940312.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110212/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110212</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914726/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914726</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae096>10.1093/ehjdh/ztae096</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110212</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Silav Zeid</dc:creator><dc:creator> Jürgen H Prochaska</dc:creator><dc:creator> Alexander Schuch</dc:creator><dc:creator> Sven Oliver Tröbs</dc:creator><dc:creator> Andreas Schulz</dc:creator><dc:creator> Thomas Münzel</dc:creator><dc:creator> Tanja Pies</dc:creator><dc:creator> Wilfried Dinh</dc:creator><dc:creator> Matthias Michal</dc:creator><dc:creator> Perikles Simon</dc:creator><dc:creator> Philipp Sebastian Wild</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study</dc:title><dc:identifier> pmid:40110212</dc:identifier><dc:identifier> pmc:PMC11914726</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae096</dc:identifier></item><item><title> Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110211/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Our ML model including in particular environmental variables exhibited a better performance than traditional statistical methods to predict in-hospital outcomes in patients admitted for AHF. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2024 Dec 16;6(2):190-199. doi: 10.1093/ehjdh/ztae094. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: While few traditional scores are available for risk stratification of patients hospitalized for acute heart failure (AHF), the potential benefit of machine learning (ML) is not well established. We aimed to assess the feasibility and accuracy of a supervised ML model including environmental factors to predict in-hospital major adverse events (MAEs) in patients hospitalized for AHF. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: In April 2021, a French national prospective multicentre study included all consecutive patients hospitalized in intensive cardiac care unit. Patients admitted for AHF were included in the analyses. A ML model involving automated feature selection by least absolute shrinkage and selection operator (LASSO) and model building with a random forest (RF) algorithm was developed. The primary composite outcome was in-hospital MAE defined by death, resuscitated cardiac arrest, or cardiogenic shock requiring assistance. Among 459 patients included (age 68 ± 14 years, 68% male), 47 experienced in-hospital MAE (10.2%). Seven variables were selected by LASSO for predicting MAE in the training data set ( <i>n</i> = 322): mean arterial pressure, ischaemic aetiology, sub-aortic velocity time integral, E/e&#39;, tricuspid annular plane systolic excursion, recreational drug use, and exhaled carbon monoxide level. The RF model showed the best performance compared with other evaluated models [area under the receiver operating curve (AUROC) = 0.82, 95% confidence interval (CI) (0.78-0.86); precision-recall area under the curve = 0.48, 95% CI (0.42-0.5), <i>F</i> 1 score = 0.56). Our ML model exhibited a higher AUROC compared with an existing score for the prediction of MAE (AUROC for our ML model: 0.82 vs. ACUTE HF score: 0.57; <i>P</i> &lt; 0.001). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Our ML model including in particular environmental variables exhibited a better performance than traditional statistical methods to predict in-hospital outcomes in patients admitted for AHF. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> STUDY REGISTRATION: ClinicalTrials.gov identifier: NCT05063097.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110211/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110211</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914725/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914725</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae094>10.1093/ehjdh/ztae094</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110211</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Benjamin Sibilia</dc:creator><dc:creator> Solenn Toupin</dc:creator><dc:creator> Nabil Bouali</dc:creator><dc:creator> Jean-Baptiste Brette</dc:creator><dc:creator> Arthur Ramonatxo</dc:creator><dc:creator> Guillaume Schurtz</dc:creator><dc:creator> Kenza Hamzi</dc:creator><dc:creator> Antonin Trimaille</dc:creator><dc:creator> Emmanuel Gall</dc:creator><dc:creator> Nicolas Piliero</dc:creator><dc:creator> Alexandre Unger</dc:creator><dc:creator> Stéphane Andrieu</dc:creator><dc:creator> Trecy Gonçalves</dc:creator><dc:creator> Fabien Picard</dc:creator><dc:creator> Vincent Roule</dc:creator><dc:creator> François Roubille</dc:creator><dc:creator> Sonia Houssany-Pissot</dc:creator><dc:creator> Océane Bouchot</dc:creator><dc:creator> Victor Aboyans</dc:creator><dc:creator> Reza Rossanaly Vasram</dc:creator><dc:creator> Thomas Bochaton</dc:creator><dc:creator> Damien Logeart</dc:creator><dc:creator> Alain Cohen Solal</dc:creator><dc:creator> Jérôme Cartailler</dc:creator><dc:creator> Alexandre Mebazaa</dc:creator><dc:creator> Jean-Guillaume Dillinger</dc:creator><dc:creator> Patrick Henry</dc:creator><dc:creator> Théo Pezel</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients</dc:title><dc:identifier> pmid:40110211</dc:identifier><dc:identifier> pmc:PMC11914725</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae094</dc:identifier></item><item><title> From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction models</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110210/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 16;6(2):159-161. doi: 10.1093/ehjdh/ztaf001. eCollection 2025 Mar.</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110210/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110210</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914716/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914716</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztaf001>10.1093/ehjdh/ztaf001</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110210</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Muhammad Ibtsaam Qadir</dc:creator><dc:creator> Ravi S Hira</dc:creator><dc:creator> Fiona R Kolbinger</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction models</dc:title><dc:identifier> pmid:40110210</dc:identifier><dc:identifier> pmc:PMC11914716</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztaf001</dc:identifier></item><item><title> Digital health programme following rhythm control in patients with atrial fibrillation: comprehensive disease management by self-monitoring, coaching, and telemedicine</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110209/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSION: This real-world analysis indicates that the hybrid holistic programme is applicable in daily practice and is actively followed by patients and improves diagnostic and therapeutic outcomes. These promising data need to be confirmed in a controlled randomized study. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 9;6(2):261-269. doi: 10.1093/ehjdh/ztae099. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Digital health is becoming increasingly powerful and available but is frequently not effectively integrated into daily practice. A hybrid programme was developed to provide holistic diagnostic and therapeutic patient care in atrial fibrillation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: Patients ( <i>n</i> = 68) were recruited at the electrophysiology centre following successful interventional restoration of sinus rhythm. The 12-month programme consists of the key modalities: (i) self-recording of one-lead electrocardiograms (ECGs), (ii) short-term remote ECG diagnosis and medical advice by video consultation, and (iii) App-based education on lifestyle and risk factor optimization with video consultation. Patients recorded 29 092 ECGs, averaging 1.42 ECGs/day. Recurrent arrhythmia was found and confirmed in 39 patients. In all cases, arrhythmia was first diagnosed based on wearable ECG over the platform, rather than by standard in-office ECG/Holter. No false positive occurred. Patients with recurred arrhythmia were treated by pulmonary vein isolation ( <i>n</i> = 17), electric cardioversion ( <i>n</i> = 17), antiarrhythmic medication ( <i>n</i> = 5), or other interventional procedures ( <i>n</i> = 1). Most patients ( <i>n</i> = 30) scheduled a video consultation over the App as the first medical touchpoint after arrhythmia occurrence. In 21 patients with arterial hypertension, systolic blood pressure was reduced by 8.0 ± 8.6 mmHg (mean ± SD), <i>P</i> &lt; 0.01. In 25 patients with obesity (body mass index ≥ 30), body weight was reduced by 3.6 ± 5.5 kg (mean ± SD), <i>P</i> &lt; 0.01. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: This real-world analysis indicates that the hybrid holistic programme is applicable in daily practice and is actively followed by patients and improves diagnostic and therapeutic outcomes. These promising data need to be confirmed in a controlled randomized study.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110209/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40110209</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914723/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">PMC11914723</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae099>10.1093/ehjdh/ztae099</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110209</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Georges von Degenfeld</dc:creator><dc:creator> Anke Langbein</dc:creator><dc:creator> Alessandra Boscheri</dc:creator><dc:creator> Maximilian O Ziegler</dc:creator><dc:creator> Jonas Demlehner</dc:creator><dc:creator> Paul Weyh</dc:creator><dc:creator> Alexander Leber</dc:creator><dc:creator> Sandra Schreier</dc:creator><dc:creator> Stefan G Spitzer</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal.数字健康</dc:source><dc:title>Digital health programme following rhythm control in patients with atrial fibrillation: comprehensive disease management by self-monitoring, coaching, and telemedicine</dc:title><dc:identifier> pmid:40110209</dc:identifier><dc:identifier> pmc:PMC11914723</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae099</dc:identifier></item><item><title> Pulsed Field Ablation of Small Vessel-Related Arrhythmias: A New Catheter and Methods</title><link/> https://pubmed.ncbi.nlm.nih.gov/40109251/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Arrhythm Electrophysiol. 2025 Mar 20:e013606. doi: 10.1161/CIRCEP.124.013606.在线印刷。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40109251/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40109251</a> | DOI: <a href=https://doi.org/10.1161/CIRCEP.124.013606>10.1161/CIRCEP.124.013606</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40109251</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Fengqi Xuan</dc:creator><dc:creator> Yunhao Li</dc:creator><dc:creator>张张</dc:creator><dc:creator>Long Lin</dc:creator><dc:creator> Daoyang Zhang</dc:creator><dc:creator>张张</dc:creator><dc:creator>Ping Zhang</dc:creator><dc:creator> Yujie Zhang</dc:creator><dc:creator> Wei Ma</dc:creator><dc:creator> Yaling Han</dc:creator><dc:creator> Zulu Wang</dc:creator><dc:creator> Ming Liang</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>循环。 Arrhythmia and electrophysiology</dc:source><dc:title> Pulsed Field Ablation of Small Vessel-Related Arrhythmias: A New Catheter and Methods</dc:title><dc:identifier> pmid:40109251</dc:identifier><dc:identifier> doi:10.1161/CIRCEP.124.013606</dc:identifier></item><item><title> Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association</title><link/> https://pubmed.ncbi.nlm.nih.gov/40109246/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is higher among people from certain racial groups, reproductive-age women compared with age-matched men, and transgender people taking estrogen hormones. Furthermore, disparities may exist in the diagnosis or management strategies of pulmonary embolism associated with race, ethnicity, sex, or... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Mar 20. doi: 10.1161/CIR.0000000000001306.在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is higher among people from certain racial groups, reproductive-age women compared with age-matched men, and transgender people taking estrogen hormones. Furthermore, disparities may exist in the diagnosis or management strategies of pulmonary embolism associated with race, ethnicity, sex, or socioeconomic status, which may correlate with poorer downstream outcomes, including recurrent pulmonary embolism, chronic thromboembolic pulmonary hypertension, or short- or long-term mortality. This scientific statement summarizes disparities in diagnosis, treatment strategies, and outcomes related to pulmonary embolism, and reviews approaches to create equitable pulmonary embolism care and address the knowledge gaps in the literature.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40109246/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40109246</a> | DOI: <a href=https://doi.org/10.1161/CIR.0000000000001306>10.1161/CIR.0000000000001306</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40109246</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Edwin A Takahashi</dc:creator><dc:creator> Akhilesh K Sista</dc:creator><dc:creator> Daniel Addison</dc:creator><dc:creator> Behnood Bikdeli</dc:creator><dc:creator> Vivian L Bishay</dc:creator><dc:creator> Sue Gu</dc:creator><dc:creator> Maureen N Hood</dc:creator><dc:creator> Diana Litmanovich</dc:creator><dc:creator> Sanjay Misra</dc:creator><dc:creator> Gautham Reddy</dc:creator><dc:creator> American Heart Association Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Peripheral Vascular Disease</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>循环</dc:source><dc:title>Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association</dc:title><dc:identifier> pmid:40109246</dc:identifier><dc:identifier> doi:10.1161/CIR.0000000000001306</dc:identifier></item><item><title> Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation</title><link/> https://pubmed.ncbi.nlm.nih.gov/40109243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description> CONCLUSIONS: The AltaValve system shows promising early procedural and clinical results for the unique anatomy of patients with atrial functional mitral regurgitation. Long-term clinical studies to demonstrate the benefit of this system are warranted. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Cardiovasc Interv. 2025 Mar 20:e014985. doi: 10.1161/CIRCINTERVENTIONS.124.014985.在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. For transcatheter mitral valve replacement, a common contraindication is the risk of left ventricular outflow tract obstruction, particularly in patients with atrial functional mitral regurgitation, who have characteristically small left ventricles. Herein, we examine the outcomes of transcatheter mitral valve replacement using the AltaValve system, which employs atrial fixation thus minimizing left ventricular outflow tract obstruction risk. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: Patients with severe, symptomatic mitral regurgitation who were treated in the AltaValve early feasibility study or on the basis of a compassionate use exemption. The definition of atrial functional mitral regurgitation required the presence of: (1) severe mitral regurgitation; (2) atrial fibrillation; (3) normal left ventricular size; (4) left ventricular ejection fraction ≥50%; and (5) absence of organic mitral disease. Procedural outcomes, 30-day survival, and echo findings are reported. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Fourteen patients (71% women, mean age 77.9 years, Society of Thoracic Surgeons Predicted Risk of Mortality score 5.4%) were treated, including 11 via transseptal delivery and 3 via a transapical approach. Technical success and mitral regurgitation reduction from severe to none/trace were achieved in all cases. There were no cases of left ventricular outflow tract obstruction. All-cause mortality at 30 days was 14% (2/14). Class III/IV New York Heart Association status was reduced from 79% at baseline to 0% at 30 days. At 30 days, 11 of 12 surviving patients had an available echocardiogram; mitral regurgitation severity was trace/none in 90.9% (10/11) and mild in 9.1% (1/11). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: The AltaValve system shows promising early procedural and clinical results for the unique anatomy of patients with atrial functional mitral regurgitation. Long-term clinical studies to demonstrate the benefit of this system are warranted.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40109243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40109243</a> | DOI: <a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014985>10.1161/CIRCINTERVENTIONS.124.014985</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40109243</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> John T Saxon</dc:creator><dc:creator> Philippe Genereux</dc:creator><dc:creator> Vlasis Ninios</dc:creator><dc:creator> Thomas Waggoner</dc:creator><dc:creator> Naeem Tahirkheli</dc:creator><dc:creator> Marek Grygier</dc:creator><dc:creator> Krzysztof Wrobel</dc:creator><dc:creator> Matti Adam</dc:creator><dc:creator> Georg Nickenig</dc:creator><dc:creator> Tsuyoshi Kaneko</dc:creator><dc:creator> Paul Sorajja</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>循环。 Cardiovascular interventions</dc:source><dc:title> Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation</dc:title><dc:identifier> pmid:40109243</dc:identifier><dc:identifier> doi:10.1161/CIRCINTERVENTIONS.124.014985</dc:identifier></item><item><title> Reduction in Left Atrial Epicardial Adipose Tissue Following Catheter Ablation for Atrial Fibrillation</title><link/> https://pubmed.ncbi.nlm.nih.gov/40109233/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320141549&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Arrhythm Electrophysiol. 2025 Mar 20:e013590. doi: 10.1161/CIRCEP.124.013590.在线印刷。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40109233/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320141549&v=2.18.0.post9+e462414">40109233</a> | DOI: <a href=https://doi.org/10.1161/CIRCEP.124.013590>10.1161/CIRCEP.124.013590</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40109233</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Nadia Chamoun</dc:creator><dc:creator> Yaacoub Chahine</dc:creator><dc:creator> Ahmad Kassar</dc:creator><dc:creator> Hala Al Yasiri</dc:creator><dc:creator> Tori Hensley</dc:creator><dc:creator> Romanos Haykal</dc:creator><dc:creator> Patrick M Boyle</dc:creator><dc:creator> Nazem Akoum</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>循环。 Arrhythmia and electrophysiology</dc:source><dc:title> Reduction in Left Atrial Epicardial Adipose Tissue Following Catheter Ablation for Atrial Fibrillation</dc:title><dc:identifier> pmid:40109233</dc:identifier><dc:identifier> doi:10.1161/CIRCEP.124.013590</dc:identifier></item></channel></rss>